Brewin Dolphin's Q3 2021: Quarterly Review

Strong growth in profits provided a boost to company shares during the third quarter of 2021, but anxiety over the future tempered those gains. In their recent report, Criticaleye Advisory Member, Brewin Dolphin, looks back at the events that have shaped markets over the past three months and highlight what to expect in 2022. 
 
Key takeaways include:
  • Some of the supply shortages can be blamed on companies that misjudged what lockdown would mean, in terms of goods demand.
  • ‘Upstream’ oil prices have been rising but, towards the end of the quarter, oil availability became an even greater problem ‘downstream’, as a shortage of HGV drivers made it difficult to get petrol to filling stations.
  • Going into 2022, it seems likely that monetary policy will tighten.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Embracing the Human-AI Partne...

Singtel faces a rapidly changing environment as geopolitics, customer expectations and AI reshape its business. In discussion with Criticaleye Senior Editor Bridgette Hall, Group Chief People & Sustainability Office...

Click here to download this insight
Reaching New Heights at Guoco...

After four years in the Group CFO role at one of Singapore’s most prominent real estate developers, GuocoLand Group, Andrew Chew talks to Jacob Ambrose Willson about stepping up from regional CFO to Group, managin...

Criticaleye Asia Podcast - Su...

Joe Dische, CFO, PropertyGuru Group, shares his perspective on what it means to succeed as a strategic CFO during times of transformation. With over two decades of experience across technology, media and telecom sectors...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 486




Aldermore Group Legal & General Concentrix Worldpay FTSE Women Leaders Review Accenture London Stock Exchange Group IBM Consulting British Land Palo Alto Networks Drax Group plc Rolls-Royce Hitachi Solutions Salesforce Lightsource bp Workday Google Eightfold AI E.ON UK AlixPartners NatWest Group NATS GlaxoSmithKline plc